Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Kobold

Showing results (71-80 of 177) with videos related to

Pageof 18
Sort By:
Oncoimmunology|October 28, 2015
Targeted activation of melanoma differentiation-associated protein 5 (MDA5) for immunotherapy of pancreatic carcinomaPeter Duewell, Ebba Beller, Sabrina V Kirchleitner, et al.
Frontiers in Immunology|September 15, 2018
PD1-CD28 Fusion Protein Enables CD4+ T Cell Help for Adoptive T Cell Therapy in Models of Pancreatic Cancer and Non-hodgkin LymphomaFelicitas Rataj, Fabian B T Kraus, Michael Chaloupka, et al.
Computers in Biology and Medicine|May 16, 2025
The role of single cell transcriptomics for efficacy and toxicity profiling of chimeric antigen receptor (CAR) T cell therapiesMoritz Thomas, Ruben Brabenec, Lisa Gregor, et al.
Frontiers in Immunology|October 31, 2022
CXCR6 expressing T cells: Functions and role in the control of tumorsNesrine Mabrouk, Thi Tran, Ikuan Sam, et al.
Frontiers in Immunology|April 25, 2022
Design and Evaluation of TIM-3-CD28 Checkpoint Fusion Proteins to Improve Anti-CD19 CAR T-Cell FunctionFranziska Blaeschke, Eva Ortner, Dana Stenger, et al.
Oncoimmunology|May 20, 2016
C-C chemokine receptor type-4 transduction of T cells enhances interaction with dendritic cells, tumor infiltration and therapeutic efficacy of adoptive T cell transferMoritz Rapp, Simon Grassmann, Michael Chaloupka, et al.
Oncotarget|August 14, 2014
T cell-recruiting triplebody 19-3-19 mediates serial lysis of malignant B-lymphoid cells by a single T cellClaudia C Roskopf, Christian B Schiller, Todd A Braciak, et al.
Oncoimmunology|September 14, 2016
A novel TLR7 agonist reverses NK cell anergy and cures RMA-S lymphoma-bearing miceGabriela Maria Wiedemann, Severin Johannes Jacobi, Michael Chaloupka, et al.
Cancer Research|April 30, 2025
Targeting Intracellular Innate RNA-Sensing Systems Overcomes Resistance to CAR T Cell Therapy in Solid TumorsNardine Soliman, Tatiana Nedelko, Giada Mandracci, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2025
Flycodes enable simultaneous preclinical analysis for dozens of antibodies in single cassette-dosed miceJustin D Walter, Michal Beffinger, Pascal Egloff, et al.
Pageof 18

Showing results (71-80 of 177) with videos related to

Sort By:
Pageof 18
Oncoimmunology|October 28, 2015
Targeted activation of melanoma differentiation-associated protein 5 (MDA5) for immunotherapy of pancreatic carcinomaPeter Duewell, Ebba Beller, Sabrina V Kirchleitner, et al.
Frontiers in Immunology|September 15, 2018
PD1-CD28 Fusion Protein Enables CD4+ T Cell Help for Adoptive T Cell Therapy in Models of Pancreatic Cancer and Non-hodgkin LymphomaFelicitas Rataj, Fabian B T Kraus, Michael Chaloupka, et al.
Computers in Biology and Medicine|May 16, 2025
The role of single cell transcriptomics for efficacy and toxicity profiling of chimeric antigen receptor (CAR) T cell therapiesMoritz Thomas, Ruben Brabenec, Lisa Gregor, et al.
Frontiers in Immunology|October 31, 2022
CXCR6 expressing T cells: Functions and role in the control of tumorsNesrine Mabrouk, Thi Tran, Ikuan Sam, et al.
Frontiers in Immunology|April 25, 2022
Design and Evaluation of TIM-3-CD28 Checkpoint Fusion Proteins to Improve Anti-CD19 CAR T-Cell FunctionFranziska Blaeschke, Eva Ortner, Dana Stenger, et al.
Oncoimmunology|May 20, 2016
C-C chemokine receptor type-4 transduction of T cells enhances interaction with dendritic cells, tumor infiltration and therapeutic efficacy of adoptive T cell transferMoritz Rapp, Simon Grassmann, Michael Chaloupka, et al.
Oncotarget|August 14, 2014
T cell-recruiting triplebody 19-3-19 mediates serial lysis of malignant B-lymphoid cells by a single T cellClaudia C Roskopf, Christian B Schiller, Todd A Braciak, et al.
Oncoimmunology|September 14, 2016
A novel TLR7 agonist reverses NK cell anergy and cures RMA-S lymphoma-bearing miceGabriela Maria Wiedemann, Severin Johannes Jacobi, Michael Chaloupka, et al.
Cancer Research|April 30, 2025
Targeting Intracellular Innate RNA-Sensing Systems Overcomes Resistance to CAR T Cell Therapy in Solid TumorsNardine Soliman, Tatiana Nedelko, Giada Mandracci, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2025
Flycodes enable simultaneous preclinical analysis for dozens of antibodies in single cassette-dosed miceJustin D Walter, Michal Beffinger, Pascal Egloff, et al.
Pageof 18